132 related articles for article (PubMed ID: 30062508)
1. Association of ki67 Index with Recurrence in Gastrointestinal Stromal Tumors.
Segales-Rojas P; Lino-Silva LS; Aguilar-Cruz E; Salcedo-Hernández RA
J Gastrointest Cancer; 2018 Dec; 49(4):543-547. PubMed ID: 30062508
[TBL] [Abstract][Full Text] [Related]
2. Prognostic angiogenic markers (endoglin, VEGF, CD31) and tumor cell proliferation (Ki67) for gastrointestinal stromal tumors.
Basilio-de-Oliveira RP; Pannain VL
World J Gastroenterol; 2015 Jun; 21(22):6924-30. PubMed ID: 26078569
[TBL] [Abstract][Full Text] [Related]
3. Gastrointestinal Stromal Tumors Risk of Recurrence Stratification by Tumor Volume is a Best Predictor Compared with Risk Based on Mitosis and Tumor Size.
Lino-Silva LS; Segales-Rojas P; Aguilar-Cruz E; Salcedo-Hernández RA; Zepeda-Najar C
J Gastrointest Cancer; 2019 Sep; 50(3):513-518. PubMed ID: 29766411
[TBL] [Abstract][Full Text] [Related]
4. Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST).
Dematteo RP; Gold JS; Saran L; Gönen M; Liau KH; Maki RG; Singer S; Besmer P; Brennan MF; Antonescu CR
Cancer; 2008 Feb; 112(3):608-15. PubMed ID: 18076015
[TBL] [Abstract][Full Text] [Related]
5. Gastrointestinal stromal tumors - a clinical-morphological study on 15 cases.
Pleşea IE; Chiuţu L; Bordu SI; Georgescu I; Georgescu EF; Ciobanu D; Mărgăritescu ND; Comănescu V; Nemeş R
Rom J Morphol Embryol; 2014; 55(2 Suppl):513-23. PubMed ID: 25178321
[TBL] [Abstract][Full Text] [Related]
6. [Clinicopathologic features of gastrointestinal stromal tumor with synchronous carcinoma].
Sun XY; Wu QS; Geng ZH; Li Q; Wang LL; Li XG
Zhonghua Bing Li Xue Za Zhi; 2013 Nov; 42(11):739-43. PubMed ID: 24447550
[TBL] [Abstract][Full Text] [Related]
7. Prognostic analysis of patients with gastrointestinal stromal tumors: a single unit experience with surgical treatment of primary disease.
Cao H; Zhang Y; Wang M; Shen DP; Sheng ZY; Ni XZ; Wu ZY; Liu Q; Shen YY; Song YY
Chin Med J (Engl); 2010 Jan; 123(2):131-6. PubMed ID: 20137358
[TBL] [Abstract][Full Text] [Related]
8. Expression of PIN1 in Gastrointestinal Stromal Tumours and its Clinical Significance.
Jiang L; Cao M; Hu J; Chen J
Anticancer Res; 2016 Mar; 36(3):1275-80. PubMed ID: 26977025
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic study of primary malignant gastrointestinal stromal tumor of the stomach, with special reference to prognostic factors: analysis of results in 140 surgically resected patients.
Fujimoto Y; Nakanishi Y; Yoshimura K; Shimoda T
Gastric Cancer; 2003; 6(1):39-48. PubMed ID: 12673425
[TBL] [Abstract][Full Text] [Related]
10. Lack of prognostic significance of connexin-43 labeling in a series of 46 gastrointestinal stromal tumors.
Boban M; Ljubicic N; Nikolic M; Tomas D; Zovak M; Bekavac-Beslin M; Belev B; Radic J; Milosevic M
Int J Biol Markers; 2011; 26(2):124-8. PubMed ID: 21607924
[TBL] [Abstract][Full Text] [Related]
11. KIT-negative gastrointestinal stromal tumor of the abdominal soft tissue: a clinicopathologic and genetic study of 10 cases.
Yamamoto H; Kojima A; Nagata S; Tomita Y; Takahashi S; Oda Y
Am J Surg Pathol; 2011 Sep; 35(9):1287-95. PubMed ID: 21836495
[TBL] [Abstract][Full Text] [Related]
12. [Prognostic significance of clinicopathologic parameters in gastrointestinal stromal tumor: a study of 156 cases].
Liang YM; Li XH; Lü YY; Lü YL; Zhong M; Pu XL; Li WM
Zhonghua Bing Li Xue Za Zhi; 2007 Apr; 36(4):233-8. PubMed ID: 17706113
[TBL] [Abstract][Full Text] [Related]
13. Biological behavior due to cell proliferation markers of gastrointestinal stromal tumors.
Menéndez P; Padilla D; Cubo T; Villarejo P; Gambí D; Menéndez JM; Colina F; García M; Lora D; Martín J
Hepatogastroenterology; 2011; 58(105):76-80. PubMed ID: 21510290
[TBL] [Abstract][Full Text] [Related]
14. Surgical treatment and prognostic analysis for gastrointestinal stromal tumors (GISTs) of the small intestine: before the era of imatinib mesylate.
Wu TJ; Lee LY; Yeh CN; Wu PY; Chao TC; Hwang TL; Jan YY; Chen MF
BMC Gastroenterol; 2006 Oct; 6():29. PubMed ID: 17062131
[TBL] [Abstract][Full Text] [Related]
15. Ki67 and p53 in gastrointestinal stromal tumors--GIST.
Neves LR; Oshima CT; Artigiani-Neto R; Yanaguibashi G; Lourenço LG; Forones NM
Arq Gastroenterol; 2009; 46(2):116-20. PubMed ID: 19578612
[TBL] [Abstract][Full Text] [Related]
16. A study of the postoperative course in cases of GIST of the stomach. The efficacy of imatinib in cases of recurrence.
Higashi D; Watanabe Y; Hirano K; Shimomura T; Egawa Y; Tomiyasu T; Ishibashi Y; Futami K; Maekawa T; Ota A; Oshige K; Iwashita A
Anticancer Res; 2009 Nov; 29(11):4893-6. PubMed ID: 20032453
[TBL] [Abstract][Full Text] [Related]
17. Surgery of upper GI gastrointestinal stromal tumors: our experience, prognostic analysis.
Kasetsermwiriya W; Nagai E; Nakata K; Nagayoshi Y; Shimizu S; Tanaka M
Hepatogastroenterology; 2015; 62(137):87-92. PubMed ID: 25911874
[TBL] [Abstract][Full Text] [Related]
18. [Roles of risk assessment and Ki-67 index in judging prognostic of gastrointestinal stromal tumors].
Liang YM; Li XH; Chen W
Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(15):1041-5. PubMed ID: 18754437
[TBL] [Abstract][Full Text] [Related]
19. [The value of (18)F-FDG PET-CT imaging in predicting the malignant potential of GIST].
Li SX; Tang MD; Lin DY; Liu DJ; Lyu QH; Zhang JP; Cai ZH
Zhonghua Zhong Liu Za Zhi; 2017 Nov; 39(11):821-827. PubMed ID: 29151288
[No Abstract] [Full Text] [Related]
20. Immunostaining of phospho-histone H3 and Ki-67 improves reproducibility of recurrence risk assessment of gastrointestinal stromal tumors.
Uguen A; Conq G; Doucet L; Talagas M; Costa S; De Braekeleer M; Marcorelles P
Virchows Arch; 2015 Jul; 467(1):47-54. PubMed ID: 25823616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
